Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...

A company spokesperson said Dexcom plans to resolve the agency's concerns but stated no design changes were made to its ...

With PFA becoming physicians’ preferred ablation method for treating AFib, Abbott is pushing to catch up with rival systems ...

Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors and ...

Sales of Beta Bionics insulin pumps spiked 145% in the fourth quarter behind solid new patient starts. Elsewhere, former ...

Thomas Payne, HCA Healthcare’s national medical director of robotics, explains how the largest U.S. health system is vetting ...

The DNA-testing company plans to sell its assets after the board rejected an acquisition proposal from Wojcicki.

CEO Bryan Hanson told investors last week that the restructuring plan would save Solventum $120 million annually.

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

Medtronic will remove one model of Pipeline Vantage devices from where they’re used and sold and will update the instructions ...

GE Healthcare, Synchron and robotics companies were among the medtech firms that used Nvidia’s GTC 2025 conference to share ...

BD, Medtronic and Abbott were among the top 10 device companies with the highest number of late reports to the FDA, the study ...